RaySearch enters agreement with Chinese distributor

Tuesday, November 29, 2011 12:55 PM
RaySearch Laboratories has entered into an exclusive distribution agreement with the Chinese distributor Kang Li Da Trading, based in Beijing. The agreement means that Kang Li Da will be fully responsible for marketing, sales and service for RaySearch’s proprietary treatment planning system RayStation on the entire Chinese market.
 
China is one of the largest radiation therapy markets globally with approximately 1300 radiation therapy clinics. There is a strong focus on improving healthcare so the radiation therapy sector is growing very rapidly and the number of clinics is expected to increase to 2,000 in less than five years. RayStation is pending regulatory clearance in China and the approval process is expected to last approximately a year and a half.
 
Kang Li Da was founded in 1996 and is a leading distributor of radiation therapy equipment in China. The company has approximately 20 employees and represents a wide range of international radiation therapy equipment suppliers serving more than 500 customers.
 
“China is the fastest growing radiation therapy market so this agreement is extremely important to us. Kang Li Da is a highly experienced distributor of radiation therapy equipment with a broad geographical coverage and excellent track record. We are very excited that they have selected to work exclusively with us within treatment planning and we are looking forward to work closely together to establish RayStation as a leading product on the Chinese market," said Johan Löf, CEO of RaySearch.
Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs